---
schema_version: "secwatch.filing_event.v1"
accession: "0001816590-23-000123"
form_type: "8-K"
ticker: "CMPS"
cik: "0001816590"
company_name: "COMPASS Pathways plc"
filed_at: "2023-09-18T23:59:59+00:00"
generated_at: "2026-06-10T15:08:11.109039+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# COMPASS Pathways appoints Daphne Karydas to Board of Directors

## Summary
- Appointment effective September 18, 2023; Karydas is President/CFO of Flare Therapeutics.
- Received initial option for 52,000 ordinary shares (or ADSs) vesting over three years.
- Annual cash retainers: $40,000 as director, $8,000 as audit/risk committee member.
- Serves as Class III director; brings over 20 years biopharma financial and strategy experience.
- No family relationships with directors/officers; no material transactions disclosed.

## SEC filing metadata
- accession: 0001816590-23-000123
- form_type: 8-K
- ticker: CMPS
- cik: 0001816590
- company_name: COMPASS Pathways plc
- filed_at: 2023-09-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1816590/000181659023000123/0001816590-23-000123-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1816590/000181659023000123/cmps-20230913.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001816590-23-000123
- JSON: https://secwatch.observer/filing/0001816590-23-000123.json
- Plain text: https://secwatch.observer/filing/0001816590-23-000123.txt

## Key facts
- Executive change
  Daphne Karydas was appointed as Director at COMPASS Pathways plc.
  - Action: appointed
  - Role: Director
  source text: On September 13, 2023, the board of directors (the “Board”) of COMPASS Pathways plc (the “Company”), upon the recommendation of its nominating and corporate governance committee, appointed Daphne Karydas to join the Board, effective September 1 8, 2023, and designated her as a Class III director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1816590/000181659023000123/0001816590-23-000123-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.